Appropriate ICD therapy in patients with idiopathic dilated cardiomyopathy - Long-term follow-up

Creative Commons License

Karaoguz R., Maydanozcu S., Altun T., Guldal M., Akyurek O., Erol Ç.

INTERNATIONAL HEART JOURNAL, cilt.47, sa.5, ss.763-773, 2006 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 47 Sayı: 5
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1536/ihj.47.763
  • Dergi Adı: INTERNATIONAL HEART JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.763-773
  • Anahtar Kelimeler: idiopathic dilated cardiomyopathy, implantable cardioverter defibrillator, IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR, ANTIARRHYTHMIC-DRUG-THERAPY, SUSTAINED VENTRICULAR TACHYARRHYTHMIAS, CONGESTIVE-HEART-FAILURE, BETA-BLOCKER THERAPY, RISK STRATIFICATION, TASK-FORCE, AMIODARONE, ARRHYTHMIAS, TACHYCARDIA
  • Ankara Üniversitesi Adresli: Evet

Özet

The implantable cardioverter defibrillator (ICD) has proved effective in preventing sudden death and decreasing mortality in randomised secondary prevention trials. Some nonrandomised studies have reported different incidences and predictors of appropriate ICD therapy in patients with idiopathic dilated cardiomyopathy (DCM). The antiarrhythmic and other medical therapies were different between the published studies and it was reported that not using beta-blockers was a predictor of appropriate ICD therapy. In the present study, we report on our long-term experience with ICD therapy in patients with DCM, the majority of whom were treated with beta-blockers and amiodarone.